Arch Therapeutics (ARTH) Stock Price, News & Analysis
Company Description
Arch Therapeutics (OTC: ARTH) is a publicly traded surgical and medical instrument manufacturing company in the Manufacturing sector.
ARTH stock has declined 86.4% over the past year. Shares last traded at $0.1608.
This page provides a comprehensive overview of ARTH stock, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Arch Therapeutics (ARTH) stock last traded at $0.1608. Over the past 12 months, the stock has lost 86.4%.
Latest News
Arch Therapeutics has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 2 with negative movement. Key topics include conferences. View all ARTH news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
ARTH Company Profile & Sector Positioning
Arch Therapeutics (ARTH) operates in the Surgical and Medical Instrument Manufacturing industry within the broader Manufacturing sector and is listed on the OTC.